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Fig. S1. GRHL2 expression pattern in the mouse placenta. GRHL2 expression analysis in control Grhl2+/- placentas at E8.0 
(A) and E9.0 (B) showed that GRHL2 was highly expressed in the primary and secondary trophoblast giant cells (TGC). 
Moreover, GRHL2 expression was detected in the chorion (ch) at E8.0 and became restricted to the BCT cells at E9.0 (B, 
arrow). In contrast, no GRHL2 staining was observed in Grhl2-/- placentas at E8.0 (C) and E9.0 (D). al, allantois; epc, 
ectoplacental cone. Scale bar: 100 μm. Related to Fig. 1. 
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Fig. S2. Defective vascularization and trophoblast 
branching in Grhl2-/- placentas. (A,B) Comparison of 
H&E-stained sections of control Grhl2+/- and mutant 
placentas showed a normal placenta development of 
Grhl2-/- embryos until E8.0. Scale bar: 250 μm. (C,D) 
Immunofluorescence staining of pan-cytokeratin (CK, 
green) and PECAM1 (red) at E11.5 revealed that Grhl2-/- 
placentas exhibited remarkably fewer fetal blood vessels 
in the labyrinth and a compact labyrinth structure 
compared to controls. Scale bar: 75 μm. (E-H) Labeling 
of the syncytiotrophoblast (STB) layers at E11.5 by 
transferrin receptor (TFRC, red, STB layer I (STB-I)) and 
ferroportin (MTP1, green, STB layer II (STB-II)) staining 
(E11.5 low magnification: E, F, scale bar: 250 μm; high 
magnification: G, H, scale bar: 50 μm) demonstrated that 
trophoblast branching was initiated in Grhl2-/- placentas, 
but that progression of labyrinth formation was disturbed, 
resulting in few and simple trophoblast branches (F) 
compared to the complex STB network in controls (E). 
Higher magnification revealed an increased thickness of 
STB-II in mutants indicated by a broadened staining of 
MTP1 (H) when compared to controls (G). al, allantois; 
ch, chorion; de, epc, ectoplacental cone; decidua; frbc, 
fetal red blood cells; mbs, maternal blood sinus. Related 
to Fig. 2. 
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Fig. S3. Spongiotrophoblast, TGC and initiation 
marker for labyrinthal morphogenesis were 
maintained in Grhl2-/- placentas. (A-D) Branch 
point labeling in the chorionic trophoblast layer by 
Gcm1 in situ hybridization (ISH) showed that 
Gcm1 expression was present at the sites of 
branch point initiation in Grhl2-/- placentas at E9.5, 
but the amount of Gcm1-positive branching 
initiation sites was markedly reduced (B) compared 
to controls (A). Gcm1 staining at E11.5 (C,D) 
detecting branch points in the labyrinth revealed a 
massively disturbed branching morphogenesis in 
Grhl2-/- placentas (D). Scale bar: 100 μm. (E,F) 
Staining of the spongiotrophoblast marker Tpbpa 
by ISH revealed that Tpbpa was present in Grhl2-/- 
placentas at E9.5. (G-N) Giant cell markers Prl3d1 
(G,H), Prl3b1 (I,J), Prl2c2 (K,L) and Hand1 (M,N) 
showed no substantial expression difference at 
E9.5. Scale bars of E9.5 placentas: 250 μm. 
Related to Fig. 2. 
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Fig. S4. Analysis of cell proliferation and apoptosis in control and Grhl2-/- placentas. (A-E) Analysis of cell proliferation via 
Ki-67 immunofluorescence staining showed no proliferation differences of the basal chorionic trophoblast (BCT) cells in controls 
and Grhl2 mutants at E9.5 (96.6% in Grhl2+/- versus 96.4% in Grhl2-/- placentas). The yellow dashed line separates the BCT 
cells from overlying trophoblast cell layers. Scale bar: 100 μm. (F-M) Cell apoptosis was analyzed by active caspase-3 
immunostaining (red). Co-staining with the epithelial basolateral marker integrin alpha 6 (ITGA6, green, E9.5, G,I) or with pan-
cytokeratin (CK, green, E11.5, K,M) facilitated the identification of BCT cells. We found no evidence for trophoblast apoptosis in 
control (F,G) and Grhl2-/- placentas (H,I) at E9.5. At E11.5, several fetal blood cells were apoptotic in Grhl2-/- placentas (L,M, 
arrows) likely due to secondary effects originating from defective feto-maternal exchange. The white dashed lines mark the 
border between epithelial trophoblasts and allantois (al). Scale bar E9.5: 100 μm. Scale bar E11.5: 250 μm. Related to Fig. 2. 
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Fig. S5. Selective inactivation of Grhl2 in epiblast-derived tissues. (A) Targeting strategy for generating a conditional Grhl2 
allele. The targeted Grhl2 construct is depicted on top. Open boxes represent exons. The diphtheria toxin A (dta) and neomycin 
resistance (neor) sequences are indicated by blue arrows. Neor was flanked by two FRT sites, exon 4 of Grhl2 by two loxP sites. 
Depicted in the middle is the targeted Grhl2 allele after electroporation and insertion into the genome of ES cells by homologous 
recombination. Random integration was reduced through the presence of the dta cassette at the 5’ end of the construct. 
Identification of ES cells carrying the targeted Grhl2 allele was achieved by G418 selection and subsequent PCR. The bottom 
diagram represents the final floxed Grhl2 allele after crossing of chimeric mice with Flp deleter mice to remove neor sequences. 
(B) Sox2Cre-mediated activation of β-galactosidase in R26R mice. Female R26R mice were bred with male Sox2Cre mice, and 
placentas of E9.5 pups were analyzed via X-gal histochemical staining. At E9.5 allantoic mesenchymal cells derived from the 
epiblast appeared in blue color, including fetal blood vessels (asterisks) arising from the allantois (al). In contrast, all 
trophectoderm-derived cell types including the basal chorionic trophoblast (BCT) cells remained unstained, indicating that 
Sox2Cre-mediated recombination occurred specifically in the epiblast-derived tissues. The dashed line marks the boundary 
between trophoblast compartment and allantois. tc, trophoblast cell(s). Scale bar: 100 μm. (C-F) Images of E9.5 littermate 
control embryos (C: Grhl2+/-; E: Grhl2flox/-), Grhl2-/- embryos (D) and Sox2Cre;Grhl2∆/- embryos (F). Grhl2-/- and Sox2Cre;Grhl2∆/- 
embryos exhibited an identical phenotype including split-face malformations, exencephaly plus anterior and lumbosacral spina 
bifida. Scale bar: 500 μm. Related to Fig. 3. 
Development | Supplementary Material
Development 142: doi:10.1242/dev.113829: Supplementary Material  
 
 
Fig. S6. Cldn4 expression in the BCT cells of Grhl2-/- placentas is unchanged on RNA and protein level. (A-D) In situ 
hybridization on E9.5 placenta sections showed the same expression intensity for Cldn4 in BCT cells of Grhl2 mutant (B,D) and 
control placentas (A,C). Boxed regions in A,B are magnified in C,D. Scale bars A,B: 250 µm. Scale bars C,D: 75 µm. (E-H) 
Immunofluorescence staining revealed strong expression of CLDN4 in the BCT cells in control Grhl2+/- (E,G) as wells as in 
Grhl2-/- placentas (F,H) compared to overlying trophoblast cell layers, respectively. CLDN4 expression levels in BCT cells of 
Grhl2-/- placentas are comparable to that of controls at E9.5 (E,F) as well as E11.5 (G,H). Scale bars: 250 µm. Related to Fig. 6. 
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Fig. S7. GRHL2 regulated SPINT1 expression in the 
BCT cells of murine placentas and was necessary 
for normal arrangement of trophoblast epithelia. 
Grhl2 ablation in murine placentas resulted in a strong 
downregulation of SPINT1 specifically in the BCT cells 
(C,D) when compared to controls (A,B) at E9.5. The 
weak expression of SPINT1 in the overlying trophoblast 
cells was maintained (C,D). Scale bar: 250 μm. Related 
to Fig. 6. 
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Fig. S8. Epiblast-specific deletion of Grhl2 
using Sox2Cre does not induce alterations in 
SPINT1 and CDH1 expression in BCT cells 
and preserves continuous basement 
membranes at the chorioallantoic interface. 
SPINT1 expression levels (A, B), CDH1 
expression levels (C, D) as well as laminin (E,F) 
and collagen IV deposition (G, H) in BCT cells at 
the chorioallantoic interface (dashed lines) of 
Sox2Cre;Grhl2∆/- embryos (B,D,F,H) are identical 
to that of their control Grhl2flox/- littermates 
(A,C,E,G). Scale bar: 25 μm. al, allantois. 
Related to Fig. 3. 
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Fig. S9. Placental expression of proteins encoded by human orthologs of the Grhl2 target gene set. Expression of the 
indicated proteins was identified in placenta sections from the Human Protein Database (Uhlen et al., 2010) 
(http://www.proteinatlas.org/). Protein name and antibody identifier (according to the Human Protein Atlas) are shown below 
each image. Note that all proteins are expressed in villous cytotrophoblasts and/or adjacent syncytiotrophoblasts in a domain  
similar to the GRHL2 expression domain. Scale bar: 100 μm. Related to Fig. 7. 
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Supplementary Tables 
Table S1. Grhl2 is crucial for embryonic survival in mice. Time course of lethality in mice resulting from intercrosses of 
Grhl2+/lacZ4 and Grhl2+/lacZ1 mice. Up to E11.5 the distribution of genotypes showed approximately Mendelian ratios (Grhl2lacZ4: 
20 % +/+, 54 % +/-, 26 % -/-; Grhl2lacZ1: 27 % +/+, 44 % +/-, 29 % -/-). No Grhl2-/- embryos were found after E11.5 in the offspring 
of Grhl2lacZ4 and Grhl2lacZ1 intercrosses. E, embryonic day; P, postnatal day. Related to Fig. 2. 
Strain Stage Number of mice 
(litter) 
Grhl2+/+ Grhl2+/- Grhl2-/- 
Grhl2+/lacZ4  
x Grhl2+/lacZ4 
E7.5 14 (2) 3 7 4 
E8.5 31 (3) 6 16 9 
E9.5 113 (12) 22 63 28 
E10.5 14 (2) 3 8 3* 
E11.5 16 (2) 4 7 5† 
E14.5 5 (1) 0 5 0 
P21 68 23 45 0 
Grhl2+/lacZ1  
x Grhl2+/lacZ1 
E8.5 20 (2) 5 8 7 
E9.5 39 (5) 12 17 10 
E10.5 7 (1) 1 4 2* 
E18.5 8 (1) 4 4 0 
P21 51 19 32 0 
*embryos developmentally retarded, †embryos dead 
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Table S2. Genes downregulated in Grhl2-/- (KO) versus control placentas (WT) at both E7.5 and E9.5 identified by 
microarray analysis. The top 150 genes for each time-point were considered. Fold rank indicated as WT/KO, P-values of log2 
transformation < 0.05, gene symbols according to Illumina resource file apart from GRHL2 core target gene set. Genes in bold 
type display genomic GRHL2 association based on at least one GRHL2 binding peak in placental extracts (gene body ± 2 kb). 
Related to Fig. 4. 
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ILMN_1246392 Prom2 224.6 71.1 3.2 0.0010 1055.5 96.0 11.0 0.0047 
ILMN_2919393 Tmem54 154.1 76.8 2.0 0.0040 500.2 106.0 4.7 0.0002 
ILMN_2846026 Rhox4d 113.8 79.5 1.4 0.0339 1108.2 308.1 3.6 0.0024 
ILMN_1227260 Lad1 114.0 74.5 1.5 0.0050 546.0 200.4 2.7 0.0068 
ILMN_1257070 Grhl2 127.5 74.3 1.7 0.0254 281.5 104.2 2.7 0.0128 
ILMN_1259206 Hrc 111.8 86.1 1.3 0.0287 703.2 271.5 2.6 0.0051 
ILMN_1243939 9530027K23Rik 109.0 82.7 1.3 0.0130 818.7 325.1 2.5 0.0017 
ILMN_1260582 LOC280487 314.8 251.0 1.3 0.0175 2221.9 906.9 2.4 0.0225 
ILMN_1217009 Rab15 924.2 499.0 1.9 0.0003 4546.8 1888.4 2.4 0.0246 
ILMN_2502226 Utf1 159.1 92.4 1.7 0.0032 558.7 236.2 2.4 0.0179 
ILMN_2717099 Irx2 143.4 89.5 1.6 0.0222 334.0 157.4 2.1 0.0250 
ILMN_2859192 Trpm5 123.6 85.9 1.4 0.0070 364.6 175.0 2.1 0.0002 
ILMN_2602938 Smpdl3b 284.8 190.2 1.5 0.0178 1368.1 704.7 1.9 0.0110 
ILMN_1251706 1600014K23Rik 120.1 83.6 1.4 0.0012 3820.5 2060.4 1.9 0.0165 
ILMN_1226661  Ldoc1 290.6 168.5 1.7 0.0472 2752.4 1498.3 1.8 0.0088 
ILMN_1220726 Satb1 637.0 439.4 1.4 0.0140 1647.9 923.8 1.8 0.0063 
ILMN_2615917 Tex19.1 420.6 208.4 2.0 0.0126 5046.5 2838.6 1.8 0.0407 
ILMN_2538597 LOC386405 241.0 171.7 1.4 0.0066 1027.8 579.9 1.8 0.0197 
ILMN_1220650 1600012P17Rik 124.9 69.8 1.8 0.0184 2829.7 1614.7 1.8 0.0001 
ILMN_3009501 Kcnk1 180.9 139.1 1.3 0.0161 608.4 348.7 1.7 0.0000 
ILMN_2518197 Tnk1 78.6 66.5 1.2 0.0303 273.1 160.9 1.7 0.0162 
ILMN_1225712 Iap 1944.6 1350.4 1.4 0.0263 20243.4 12036.5 1.7 0.0447 
ILMN_1229393 LOC100040016 83.4 65.3 1.3 0.0103 132.4 79.6 1.7 0.0421 
ILMN_2648169 Sfn 153.4 115.9 1.3 0.0317 506.7 304.9 1.7 0.0061 
ILMN_2835771 Plac1 2125.8 1149.5 1.8 0.0233 11872.3 7177.7 1.7 0.0183 
ILMN_2637094 Pcsk6 230.0 141.3 1.6 0.0182 2821.6 1750.1 1.6 0.0113 
ILMN_2764846 Tcfap2a 350.7 187.7 1.9 0.0042 371.6 234.5 1.6 0.0307 
ILMN_1221585 D030026A21Rik 165.3 134.4 1.2 0.0456 1293.4 823.3 1.6 0.0442 
ILMN_2629335 Nxf7 455.9 269.6 1.7 0.0393 1135.5 730.7 1.6 0.0335 
ILMN_2673776 E2f2 204.8 171.8 1.2 0.0032 406.6 263.5 1.5 0.0005 
ILMN_2837779 Trpv2 258.7 188.6 1.4 0.0266 1791.2 1175.6 1.5 0.0271 
ILMN_1237186 Spint1 413.1 329.5 1.3 0.0092 2628.9 1733.9 1.5 0.0432 
ILMN_2588474 Homer2 848.9 608.8 1.4 0.0158 3343.3 2212.5 1.5 0.0299 
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Table S3. Top overlapping gene ontology terms (P<0.05) for genes displaying GRHL2 association based on placental 
ChIP-seq data (gene body ± 2 kb) and for the intersection of the top 150 downregulated genes in E7.5 and E9.5 Grhl2-/- 
versus control placentas as determined by microarray analysis. GO terms with less than four ancestor terms, less than two 
or more than 1000 genes in term and less than two target genes in term have been removed. Gene ontology was performed 
using HOMER. Related to Fig. 4. 
Top overlapping ontology terms of ChIP-seq- and microarray data 
  ChIP-seq Microarray 
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GO:0030855 epithelial cell 
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0,0364 2 Sfn,Tfap2a 
GO:0043588 skin 
development 





GO:0014020 primary neural 
tube formation 


































GO:0008544 epidermis 0,0121 195 33 Tfap2c,Fa2h,Pdgfa,Gab1,Atp2c1,Tcf7l1 0,0020 3 Satb1,Sfn,Tf
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Table S4. Primers used for the validation of neor excision in floxed Grhl2 mice, genotyping of floxed Grhl2 mice without 
neor and Flp deleter mice, Sox2Cre and R26R-LacZ mice. Related to Fig. 3. 
 Forward primer sequence 5‘ to 3‘ Reverse primer sequence 5‘ to 3‘ PCR 
product 
length 
floxed exon 4 with neor 
floxed exon 4 without neor 








   683 bp 
541 bp 
floxed exon 4 
























Table S5. Primers used for screening of ES cells to generate floxed Grhl2 mice. Related to Fig. 3. 
  Forward primer sequence 5‘ to 3‘ Reverse primer sequence 5‘ to 3‘ PCR product length 
Validation of homologous 
recombination at 5‘ end 
ACAAGGAAGGTGAGGATGAG CTAGTGAGACGTGCTACTTC 2349 bp floxed allele 
Validation of homologous 
recombination at 3‘ end 
CCAACCTTCCCTTTCCATTC AGAGGACTTGAAGGTCGGAG 672 bp floxed allele 
564 bp wild-type 
allele 
Table S6. Riboprobes for in situ hybridization. Related to Fig. S3. 
Target gene Linearization for anti-sense probe Polymerase for anti-sense probe Insert size Reference 
Tpbpa EcoRI Sp6 630 bp Francois Guillemot 
Prl3d1 HindIII Sp6 800 bp Malgorzata Gasperowicza/ 
James Cross 
Prl3b1 HindIII T7 815 bp Janet Rossant 
Prl2c2 HindIII T7 800 bp Janet Rossant 
HandI SalI T7 1475 bp James Cross 
Gcm1 XhoI T7 1521 bp Malgorzata Gasperowicza/ 
James Cross 
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Table S7. qPCR primers for expression analysis of the Grhl2 target gene set. Related to Fig. 5. 
 
 
Table S8. ChIP qPCR primer sequences for validation of the GRHL2 ChIP-seq peak regions. Related to Fig. 5.  
 
Target gene Forward primer sequence 5’ to 3’ Reverse primer sequence 5’ to 3’ 
Spint1 ATGTGCAAGGAATCTCACCGAA CACAGCGTTCACTGAATGGG 
Kcnk1 TCTGTGCTGGAGGATGACTG TGATGTGAACCAGGTCTTCG 
Smpdl3b CAACACAGGTGCCCCCATAA TGTACATTCGCCTGCCTCAG 
Plac1 GTGTCCTGTGCTGCCCCTCG GGTGGGCAGCTGCAGTTGGG 
Tmem54 GGAGGAGAAGGATGGAAGCG CAGCACCTTCCGGAACTCAT 
Prom2 CCTCGTCTTCGTCACTTTCC TCCAGGTGCTTATCCAGGTC 
Ldoc1 CGCCTTTTCATTCCAACCCC ATCGCTGGAACTCCGAACAG 
Lad1 AGAAACACCCTTAACCCGCA CAGACGCAGATTCTCCTTTCG 
Rab15 GATGTGCTGTTCCGGCTACT GCTCGCCGATAGTACTGCTT 
Tnk1 CCCATCACTATCATTGAGGGCA ATCTTCGTTCTGTGGCTCCG 
1600014K23Rik TGACCCTTGGGAGAATTGCC GCAGAAGGCTCTGGTTGAGT 
Actb CTAAGGCCAACCGTGAAAAG TCTCAGCTGTGGTGGTGAAG 
Tex19.1 CCATGGGGAACAGACGAAGA ACATAAAGGGACCCCAATCCC 
Grhl2 ACCATCGGGAACATTGAAGA TCCGGTCCTCTGTAGGTTTG 
Tfap2a CATCGAGGACGTCCCGCACG TCCCTGGCTAGGTGGACGGC 
Target gene Forward primer sequence 5’ to 3’ Reverse primer sequence 5’ to 3’ 
Spint1 ATCTCCTCAGCCCTGGTTTG GAGCCAGTTGGACAGGAGTT 
Plac1 ATGGTCAGACCCAGGGAAGA TAGGAAACCGCTGCAGAACC 
Prom2 GGCCGTGCATCCTTCTGTAG GGAGCCCAAACCTGTCGG 
Tmem54 CGATGGAGACCCCTTAGAGC CAGGCCGCCCTCGTTC 
Tcfap2a GCGGGCTTAGAGTTGTCTGA CTGGTTGTCGGAACAAGCG 
Ldoc1 TGCTCTGAAACTCACTTTGGC AGGGACCTGGAAAATCGCTG 
Tex19.1 CAGAGGAACGTTGCTACACCA ATCAGTGAGCAGCATCGCAG 
Kcnk1 CAACATCACCCAGGCCAGT TGTCTATGGTGGAGGAGGGAT 
Tnk1 ACTCTGCTTTCCTCATAGCCC GTAAGCCAAAATCTGGCCCC 
Smpdl3b TCCTCCAATCAAGCGCACG AGTTATCCTTGGCGGATGGC 
1600014K23Rik ATCTGTAGCGCACTCCAAAGTT CCTGGAAAGCCAATCACAGGAA 
Lad1-peak1 AGCTCTTGGGTTTCTGCCG GAACCCAAAGATCGGGGTCA 
Lad1-peak2 CAGCCCCACCTAGTGGATAAG GGGTTGTGACAGGCCAATCT 
Rab15 TAGGCTCACCTGGTTCTCCG CCCCTCCCCACTCTGAAGAA 
Control locus CGTGGCTCATGTGTCAACTAA CGATGGGACATGGTAGTGTCT 
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Supplementary Experimental Procedures 
Microarray analysis 
Total RNA from E7.5 trophectoderm-derived tissues and E9.5 placenta was isolated using the RNeasy 
Mini Kit (Qiagen, Hilden, Germany) according to manufacturer’s instructions including treatment 
with RNase-free DNase I (Qiagen, Hilden, Germany). Subsequently, RNA was amplified for 
hybridization with Illumina® MouseWG-6 v2.0 Expression BeadChips (San Diego, CA, USA) using 
the Ambion® Illumina® TotalPrep™ RNA Amplification Kit (Life Technologies, Darmstadt, 
Germany). After quantile normalization of the data, we filtered out the genes with a valid RefSeq ID 
(referring to the annotation file provided by Illumina; http://www.switchtoi.com/annotationfiles.ilmn) 
and with a P-value of the respective log2-transformed expression values less than 0.05 using Student's 
t test. For heat-map generation, gene expression values were maximum normalized on a per-gene basis 
for E7.5 and E9.5, separately. 
The publicly deposited data samples from human placenta were downloaded from GEO 
(http://www.ncbi.nlm.nih.gov/geo/), namely the sets under the following URL's: 
http://www.ncbi.nlm.nih.gov/sites/GDSbrowser?acc=GDS4037, 
http://www.ncbi.nlm.nih.gov/sites/GDSbrowser?acc=GDS3467 and 
http://www.ncbi.nlm.nih.gov/sites/GDSbrowser?acc=GDS2990 (Huuskonen et al., 2008; Mikheev et 
al., 2008; Founds et al., 2009). For our analysis, we only compared probes with the same Affymetrix 
ID. Log2 transformed data was re-transformed if necessary. As mentioned in the text, the potential 
GRHL2 target genes show a high correlation with Grhl2 itself and among each other. The high 
correlation coefficients of all targets with Grhl2 are with a probability of less than 0.01 due to random 
effects. For this P-value, correlation coefficients of all genes from the datasets with Grhl2 have been 
calculated. Clearly, taking n genes randomly from the dataset and having m (m≤n) correlation 
coefficients above a level r0 follows a hypergeometric distribution. Setting r0 to be the minimum 
correlation coefficient among the core target module and having m=n=12 (plus number of genes and 
number of genes with a correlation coefficient ≥r0), led to the respective P-value. 
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Biocomputational analysis of ChIP sequencing 
Following initial quality filtering and genome alignment using Bowtie software (Langmead et al., 
2009), we obtained around 30 million aligned reads per experiment. To predict GRHL2-associated 
genomic regions, we used MACS for peak analysis (Zhang et al., 2008) on GRHL2 ChIP samples and 
on IgG control ChIP samples as background control (threshold P-value 1x10-5). This yielded 5,282 
peaks from mouse placenta. The peaks were ranked according to the intrinsic scores provided by 
MACS (negative log10 transform of the peak's P-value). Motif finding was then performed using 
MEME (Bailey et al., 2009) in the top 10% of all peaks in a 50 bp window around the peak's summit 
and optimized for de novo detection of 8-9 bp motifs. Motif enrichment in a given sequence set was 
done by using MAST (Bailey and Gribskov, 1998) and FIMO (Grant et al., 2011). The resulting 
GRHL2 motif was subjected to TOMTOM analysis (Bailey et al., 2009) for comparison with known 
transcription factor recognition matrices. Visualization of the ChIP data was carried out using the 
Integrative Genome Viewer provided by the Broad Institute (Robinson et al., 2011). 
For the functional characterization of the GRHL2 ChIP peak at the 3’ end of Spint1, we used 
H3K4me1 and H3K27ac ChIP-seq data on mouse placentas from ENCODE. The respective files can 
be found under wgEncodeLicrHistonePlacH3k04me1FAdult8wksC57bl6StdPk and 
wgEncodeLicrHistonePlacH3k27acFAdult8wksC57bl6StdPk. We did not use the provided peak tracks 
and computed them using MACS with the same parameters as for our own data.  
Further analysis and visualization of microarray and ChIP-seq data 
After peak finding, we found peak-related genes using the closest method of the bedtools suite 
(Quinlan and Hall, 2010). The respective gene coordinates were obtained from the refGene table of 
UCSC table browser (http://genome.ucsc.edu/cgi-bin/hgTables?command=start). Setting a distance 
threshold of 2 kb produced a list of genes near a ChIP peak area. Analysis of our gene expression data 
also produced gene lists. We then performed an ID conversion using DAVID to entrez gene ID 
(Huang da et al., 2009b, a) and a manual conversion of gene names not matched by DAVID using the 
RefSeqGene web page (http://www.ncbi.nlm.nih.gov/refseq/rsg/). After this, the respective lists were 
intersected to yield the desired target gene set. All list operations were done by self-written Python 
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programs. The visualization as well was performed by self-written programs in Python using the 
matplotlib package (http://matplotlib.org/). 
ChIP peak annotation to the respective genomic regions (Promoter/TSS, Intergenic etc.) was done 
using the HOMER software package (Heinz et al., 2010). Random genomic intervals were generated 
using the shuffle method in the bedtools suite. 
Animals 
Mice with a conditional (floxed) Grhl2 allele were obtained from embryonic stem (ES) cells 
containing a targeted Grhl2 gene with the fourth exon flanked by loxP sites (see supplementary 
Material Fig. S5A). Upstream from the floxed exon 4, a neomycin resistance sequence (neor) flanked 
by two FRT sites was integrated for positive selection. The targeted ES cell clones were generated by 
electroporation and integration of the targeted construct into the genome of mouse KV1 ES cells 
(derived from 129B6 hybrid mice) through homologous recombination. Random integration was 
reduced by the presence of a diphtheria toxin A (dta) cassette at the 5’ end of the construct. Following 
G418 selection, a screening for ES cell clones positive for homologous recombination was carried out 
by PCR using primers depicted in supplementary Material Table S5. A positive ES cell clone was 
injected into C57BL/6 blastocysts to generate Grhl2flox/+ mice via standard procedures. Excision of 
neor was achieved through breeding of Grhl2flox/+ mice with Flp deleter mice (Farley et al., 2000). 
Grhl2flox/flox mice were viable and fertile. Breeding of female Grhl2flox/flox mice with heterozygous 
Grhl2+/- males carrying the Sox2Cre transgene (Sox2Cre;Grhl2+/-) enabled selective Grhl2 inactivation 
in the epiblast-derived mouse embryo corpus and in the epiblast-derived extra-embryonic membranes 
(amnion, yolk sac, allantois) without impairment of the trophectoderm-derived trophoblast lineages 
through generating Sox2Cre;Grhl2∆/- mice (Hayashi et al., 2002). Grhl2flox/flox and Sox2Cre;Grhl2∆/- 
mice were on a mixed 129/C57BL/6 genetic background. Genotyping was done by PCR with primers 
indicated in supplementary Material Table S4. For timed pregnancies, breeding females were checked 
for vaginal plugs in the morning. The plug date was considered as embryonic day 0.5 (E0.5). 
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Antibodies 
The following antibodies were used: anti-GRHL2 (HPA004820, Sigma-Aldrich, Hamburg, Germany, 
1:200 (immunofluorescence), 6 µg per immunoprecipitation), anti-cleaved caspase 3 (G7481, 
Promega, Mannheim, Germany, 1:250), anti-CD71 (MCA1033GA, AbD Serotec/MorphoSys AG, 
Puchheim, Germany, 1:150), anti-MTP1 (MTP11-A, Alpha Diagnostic, San Antonio, Texas, 1:150), 
anti-pan-cytokeratin-FITC (F3418, Sigma-Aldrich, Hamburg, Germany, 1:100), anti-laminin (L9393, 
Sigma-Aldrich, Hamburg, Germany, 1:150), anti-Ki-67 (M7249, Dako, Hamburg, Germany, 1:200), 
anti-PECAM1 (550274, BD Pharmingen, Heidelberg, Germany, 1:100), anti-TCFAP2C (sc-8977 (H-
77), Santa Cruz, Heidelberg, Germany, 1:200), anti-collagen IV (AB756, Millipore Corporation, 
Billerica, MA, 1:150), anti-CDH1 (3195S, New England Biolabs, Frankfurt am Main, Germany, 
1:250), anti-SPINT1 (AF1141, R&D Systems Inc, Wiesbaden-Nordenstadt, Germany, 1:50), anti-
ITGA6 (MCA699GA, AbD Serotec/MorphoSys AG, Puchheim, Germany, 1:150), rabbit Cldn4 (36-
4800, Life Technologies GmbH, Darmstadt, Germany, 1:250), rabbit IgG (011-000-003, Jackson 
ImmunoResearch, Newmarket, UK, 6 µg per immunoprecipitation). 
Immunofluorescence staining and confocal microscopy 
Cryo-embedded tissues were cut into 16 µm thick sections and subjected to immunofluorescence 
staining. After incubation of tissue sections in blocking buffer (PBS/1% BSA/0.05% triton-X-100) for 
1 hour, primary antibodies were incubated overnight at 4°C. Primary antibodies were detected with 
secondary antibodies diluted in blocking buffer and labeled by Cy2, Cy3 or Cy5 (Jackson 
ImmunoResearch, Newmarket, UK). Nuclei were visualized using TO-PRO -3 iodide (Life 
Technologies GmbH, Darmstadt, Germany). Fluorescent microscopy was done on an inverted TCS 
SP5 tandem confocal microscope (Leica Microsystems GmbH, Wetzlar, Germany). For comparing 
relative intensity of immunofluorescence staining, the z-plane was adjusted for maximal fluorescence 
intensity, and image acquisition settings were maintained to be identical for all samples. 
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GRHL2 immunohistochemistry 
For immunohistochemistry, we used the EnVision System-HRP (AEC) kit for the use with rabbit 
primary antibodies (Dako, Hamburg, Germany) according to manufacturer’s instructions. Tissues 
were fixed in PBS/4% PFA for 1 hour at 4°C, dehydrated, embedded in paraffin and cut into 10 µm 
thick sections. GRHL2 antigen retrieval was done by incubation for 20 minutes at 100°C in 10 mM 
citrate buffer pH 6.0. 
Hematoxylin and Eosin (H&E) staining 
Paraffin-embedded tissue was cut into 5 µm thick sections. Before staining, slides were incubated for 
30 minutes to 2 hours at 62°C laying upright in a rack to melt off the paraffin wax. After drying for 30 
minutes at room temperature tissue sections were dewaxed by incubating two times in toluol for 5 
minutes and rehydrated using a descending ethanol series (100% ethanol: 2 x 2 minutes, 96% ethanol: 
2 x 2 minutes, 80% ethanol: 1 x 2 minutes, 70% ethanol: 1 x 2 minutes, ddH2O: 1 x 2 minutes). Tissue 
sections were then incubated for 2 to 3 minutes in hemalum solution acid according to Mayer and 
washed for 30 s in tap water for staining of the nuclei. After short incubation in 1% eosin Y/water 
solution slides were washed again in tap water and covered with glycerin gelatin and cover slip. 
Human tissue samples 
We included non-laboured placenta samples from complicated and uncomplicated pregnancies 
delivered by elective Cesarean section at Oslo University Hospital, Oslo, Norway to analyse 
expression correlation of GRHL2 and SPINT1. The Regional Committee of Medical Research Ethics 
in Eastern Norway approved the study and informed written consent was obtained from each 
participant (ref 529-02162). Placental biopsies from a centrally located normally looking cotyledon 
(from the center of the cotyledon; omitting the maternal surface and fetal membrane tissues) were 
obtained following Cesarean sections from 56 preeclamptic women and 28 women with normal 
normotensive and uncomplicated pregnancies. 
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In situ hybridization 
In situ hybridization on placenta tissue sections was carried out as described previously (Hammes et 
al., 2001; Schmidt-Ott et al., 2007). Riboprobes were produced from the appropriate plasmids (Table 
S6). Digoxigenin-labeled cRNA was produced using T7 or T3 polymerase as indicated. 
RNA extraction, cDNA synthesis and real-time PCR 
Total RNA was isolated using RNeasy Mini Kit (Qiagen, Hilden, Germany) according to 
manufacturer's instructions including treatment with RNase-free DNase I (Qiagen, Hilden, Germany). 
First-strand cDNA synthesis was carried out from 500 ng of total RNA from each sample as template 
with the RevertAid™ First Strand cDNA Synthesis Kit (Fermentas/Fisher Scientific, Schwerte, 
Germany) according to manufacturer's instructions. Real-time PCR was performed using cDNA as 
template for expression analyses or DNA for ChIP-seq validation, MESA GREEN qPCR MasterMix 
Plus for SYBR Assay Rox (Eurogentec, Cologne, Germany) and primers at a final concentration of 
200 nM each. For primer sequences used for the validation of Illumina microarray results and for the 
validation of the GRHL2 ChIP-seq peaks see Table S7 and S8, respectively. Relative levels of mRNA 
expression were normalized for beta-actin mRNA expression for expression analyses or for total input 
for ChIP experiments and calculated according to the ddCT method. Statistical significance of 
differences between two groups was analyzed using two-sided Student’s t-test. 
Electron microscopy 
E9.5 placentas were fixed with 3% glutaraldehyde in 0.1 M sodium cacodylate buffer and 2 mM CaCl2 
for 24 hours at 4°C. After washing twice in 0.1 M sodium cacodylate buffer for 30 minutes, placentas 
were post-fixed in 1% osmium tetroxide (OsO4) in 0.1 M cacodylate buffer for 2 hours. Afterwards, 
placentas were washed again twice in 0.1 M sodium cacodylate buffer for 30 minutes, respectively. 
Samples were dehydrated in a graded ethanol series (70% ethanol: 2 x 20 minutes, 90% ethanol: 2 x 
20 minutes, 100% ethanol: 2 x 20 minutes) and propylene oxide (2 x 10 minutes) and embedded in 
Poly/Bed 812R (Polysciences, Eppelheim, Germany). Polymerization was done at 60°C for 2 to 3 days. 
Ultrathin sections (70 nm) were contrasted with uranyl acetate and lead citrate and examined with a 
Development | Supplementary Material
Development 142: doi:10.1242/dev.113829: Supplementary Material  
 
Morgagni electron microscope (FEI). Digital images were taken with a Morada CCD camera and the 
iTEM software (Olympus Soft Imaging Solutions GmbH, Münster, Germany). 
Analysis of fluorescence intensity 
Fluorescence intensity of immunofluorescence-stained tissue sections was analyzed using the image 
editing software ImageJ. Immunofluorescence images were first converted into grayscale. Then, BCT 
cells and overlying chorionic trophoblast cells were separately selected using the freeform selection 
tool and the level of fluorescence in these regions was analyzed. Mean gray values were determined, 
mean fluorescence of background readings was subtracted and the relative expression levels were 
calculated and plotted. 
Importantly, for comparing different samples, staining procedures of Grhl2 control and Grhl2-/- 
placenta sections were performed with identical reagents and in parallel. In addition, image acquisition 
was also done in parallel using identical image acquisition settings and exposure times.  
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